Literature DB >> 14666677

A role for the pituitary tumor-transforming gene in the genesis and progression of non-small cell lung carcinomas.

Shoko Honda1, Moriaki Hayashi, Yasuhito Kobayashi, Yuichi Ishikawa, Ken Nakagawa, Eiju Tsuchiya.   

Abstract

BACKGROUND: The product of the pituitary tumor-transforming gene (PTTG) inhibits chromatid separation, which is considered to promote chromosome instability, especially in the absence of the p53 gene product, and also induces basic fibroblast growth factor (bFGF) production. Its expression and these variables in primary non-small cell carcinomas (NSCLCs) of known p53 status were examined.
MATERIALS AND METHODS: Comparative genomic hybridization analysis of 78 lesions revealed a wide range of total (gain + loss) chromosomal imbalance numbers (tCINs). Seven each with the highest and lowest tCINs were examined for PTTG mRNA by semi-quantitative RT-PCR and bFGF production immunohistochemically.
RESULTS: Mean relative values for PTTG mRNA for the tumors and corresponding normal lung tissues were 1.46 and 0.88, respectively, the difference being statistically significant. Overexpression of bFGF was observed in 12 out of 14 with intense immunostaining of carcinoma cells, in contrast to the weak or lack of staining in normal lung tissues. However, relative PTTG values did not correlate with tCINs or immunoreactivity for bFGF among the tumors regardless of the p53 status.
CONCLUSION: The results indicate that overexpression of PTTG plays a role in the genesis and progression of NSCLCs, although its effects on CINs and bFGF production may be obscured by other complicating factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14666677

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  16 in total

1.  Expression of PTTG1 and PTEN in endometrial carcinoma: correlation with tumorigenesis and progression.

Authors:  Zhen-Zhong Feng; Jia-Wei Chen; Zhao-Rui Yang; Guang-Zhong Lu; Zhao-Gen Cai
Journal:  Med Oncol       Date:  2010-12-22       Impact factor: 3.064

Review 2.  The emerging role of pituitary tumor transforming gene in tumorigenesis.

Authors:  Jacob Tfelt-Hansen; Deepthi Kanuparthi; Naibedya Chattopadhyay
Journal:  Clin Med Res       Date:  2006-06

3.  Long noncoding RNA CCAT2 is activated by E2F1 and exerts oncogenic properties by interacting with PTTG1 in pituitary adenomas.

Authors:  Dongxia Fu; Yunna Zhang; Haibin Cui
Journal:  Am J Cancer Res       Date:  2018-02-01       Impact factor: 6.166

4.  Overexpression of the pituitary tumor transforming gene upregulates metastasis in malignant neoplasms of the human salivary glands.

Authors:  Jia Liu; Yuguang Wang; Hong He; Wulong Jin; Rong Zheng
Journal:  Exp Ther Med       Date:  2015-06-10       Impact factor: 2.447

5.  PTTG induces EMT through integrin αVβ3-focal adhesion kinase signaling in lung cancer cells.

Authors:  P P Shah; M Y Fong; S S Kakar
Journal:  Oncogene       Date:  2011-11-14       Impact factor: 9.867

6.  Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transition.

Authors:  Y Tong; Y Tan; C Zhou; S Melmed
Journal:  Oncogene       Date:  2007-03-12       Impact factor: 9.867

7.  MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1.

Authors:  Tongle Zhi; Kuan Jiang; Xiupeng Xu; Tianfu Yu; Weining Wu; Er Nie; Xu Zhou; Xin Jin; Junxia Zhang; Yingyi Wang; Ning Liu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 8.  Mitotic chromosomal instability and cancer: mouse modelling of the human disease.

Authors:  Juan-Manuel Schvartzman; Rocio Sotillo; Robert Benezra
Journal:  Nat Rev Cancer       Date:  2010-02       Impact factor: 60.716

9.  PTTG promotes invasion in human breast cancer cell line by upregulating EMMPRIN via FAK/Akt/mTOR signaling.

Authors:  Hui Gao; Feng Zhong; Jing Xie; Jianjun Peng; Zhiwu Han
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

10.  Loss of cytoplasmic CDK1 predicts poor survival in human lung cancer and confers chemotherapeutic resistance.

Authors:  Chunyu Zhang; Abdel G Elkahloun; Matthew Robertson; Joell J Gills; Junji Tsurutani; Joanna H Shih; Junya Fukuoka; M Christine Hollander; Curtis C Harris; William D Travis; Jin Jen; Phillip A Dennis
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.